Best Peptides for Anti-Ageing
Anti-ageing peptides have emerged as one of the most promising frontiers in longevity research, offering targeted approaches to cellular repair, mitochondrial function, and DNA protection. Unlike broad-spectrum supplements, peptides work at the molecular level to address specific hallmarks of ageing — from oxidative stress to telomere shortening. Research indicates these bioactive compounds can support everything from skin elasticity to cognitive function, though individual responses vary significantly.
The UK peptide landscape offers access to several well-researched anti-ageing compounds, each with distinct mechanisms and evidence profiles. GHK-Cu leads in skin regeneration studies, while Epithalon shows promise for cellular longevity. MOTS-c targets metabolic ageing, and SS-31 focuses on mitochondrial protection. Understanding these differences is crucial for making an informed choice.
This guide evaluates the current evidence, practical considerations, and real-world applications to help you navigate the anti-ageing peptide market. We'll examine dosing protocols, cost-effectiveness, and how to integrate these compounds into a comprehensive longevity strategy.
GHK-Cu
GHK-Cu stands out as our top anti-ageing peptide for several compelling reasons. With over 40 years of research and more than 100 published studies, it has the strongest evidence base of any anti-ageing peptide available in the UK. The copper-binding tripeptide demonstrates remarkable versatility, supporting collagen synthesis, wound healing, and cellular repair mechanisms simultaneously.
What sets GHK-Cu apart is its proven safety profile and measurable results. Studies show significant improvements in skin thickness, elasticity, and firmness within 8-12 weeks of consistent use. The peptide also exhibits anti-inflammatory properties and may support hair growth — offering multiple anti-ageing benefits in one compound.
From a practical standpoint, GHK-Cu offers excellent value. Effective doses (1-2mg daily) are relatively affordable compared to other anti-ageing peptides, and both topical and subcutaneous protocols show efficacy. The compound's stability and ease of reconstitution make it accessible for beginners, while its stacking potential appeals to advanced users. Compare GHK-Cu with alternatives to see why it consistently ranks highest for evidence-to-cost ratio in anti-ageing applications.
Ranked recommendations
| # | Peptide | Why | Dose | Evidence |
|---|---|---|---|---|
| 1 | GHK-Cu | Strongest evidence base with 40+ years of research. Proven skin regeneration and anti-inflammatory effects. | 1-2mg daily (subcutaneous) or 0.5-1mg topical | Strong |
| 2 | Epithalon | Promising telomerase activation research and longevity studies. Well-established dosing protocols. | 5-10mg daily for 10 days, cycled quarterly | Moderate |
| 3 | MOTS-c | Emerging mitochondrial research with metabolic anti-ageing benefits. Limited human studies but promising mechanisms. | 5-15mg 2-3x weekly | Preliminary |
| 4 | SS-31 | Specialised mitochondrial peptide with potential for cellular energy optimisation. Very limited human data. | 2-5mg daily | Preliminary |
How to choose
Selecting the right anti-ageing peptide depends on your experience level, specific goals, and budget. Beginners should start with GHK-Cu due to its extensive safety data and visible results. The compound's forgiving dosing window and proven efficacy make it an ideal entry point into peptide therapy.
Budget considerations significantly impact choice. GHK-Cu offers the best value-to-evidence ratio, whilst Epithalon requires higher upfront costs but may provide broader systemic benefits. Use our cost calculator to compare long-term expenses across different protocols.
Legal status remains crucial in the UK. All featured peptides exist in a regulatory grey area — they're not medicines but aren't explicitly banned for research purposes. Review our UK peptide legality guide for current regulations and import considerations.
Advanced users might consider stacking protocols combining complementary mechanisms. GHK-Cu pairs well with MOTS-c for comprehensive cellular repair, whilst Epithalon can complement SS-31 for mitochondrial longevity. However, start with single compounds to assess individual responses before combining.
Specific goals should drive selection: choose GHK-Cu for visible skin improvements, Epithalon for systemic longevity, MOTS-c for metabolic health, or SS-31 for energy optimisation. Consider your primary ageing concerns and match them to each peptide's strongest evidence areas.
Frequently asked questions
Which anti-ageing peptide shows the fastest results?
GHK-Cu typically shows the fastest visible results, with skin improvements often noticeable within 4-6 weeks. However, deeper anti-ageing effects from peptides like Epithalon may take 3-6 months to manifest significantly.
Can I stack multiple anti-ageing peptides together?
Yes, many users successfully combine anti-ageing peptides. Common stacks include GHK-Cu with MOTS-c, or Epithalon with SS-31. Start with individual peptides first, then explore stacking protocols once you understand your response to each compound.
Are anti-ageing peptides legal to buy in the UK?
Anti-ageing peptides exist in a regulatory grey area in the UK. They're not licensed medicines but aren't explicitly prohibited for research purposes. Check our UK peptide legality guide for current regulations and safe purchasing practices.
How long should I cycle anti-ageing peptides?
Cycling depends on the specific peptide. GHK-Cu can be used continuously, whilst Epithalon is typically cycled (10 days on, 3 months off). MOTS-c and SS-31 protocols vary. Always start with manufacturer recommendations and adjust based on your response.
Do I need to inject anti-ageing peptides or are there alternatives?
While subcutaneous injection is most common, some alternatives exist. GHK-Cu works topically for skin benefits, and nasal sprays may be available for certain peptides. However, injection typically provides superior bioavailability for systemic anti-ageing effects.